Glucagon-like peptide 1 receptor agonists (GLP-1 RAs), used for diabetes or obesity, are associated with a significantly lower quality of bowel preparation and a greater need for repeat colonoscopy, ...

Inadequate bowel preparation negatively impacts the quality of colonoscopy, potentially resulting in missed lesions and the need for repeat procedures. Although gut motility plays a key role in bowel ...

The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or obesity is associated with a lower quality of bowel preparation among patients undergoing colonoscopy, according to a ...

An adequate bowel preparation is defined as one that permits the detection of all polyps >5 mm in size. While providing a conceptual framework for understanding an acceptable preparation, this ...

Long waiting times for appointments as well as patients’ education levels increase the risk of poor bowel preparation in adult patients undergoing colonoscopy, according to a report in BMC ...

In a study of colonoscopies involving poor bowel preps, 42 percent of polyps were discovered only in a repeat colonoscopy, according to a report in GIE: Gastrointestinal Endoscopy. The miss rate for ...

FORT LAUDERDALE, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or “Motus GI” or “the Company”), a medical technology company focused on improving endoscopic outcomes ...

In updated consensus recommendations published online March 4 in the American Journal of Gastroenterology, additional guidance is presented for optimizing bowel preparation quality for colonoscopy.

The low-volume bowel preparation MoviPrep provided a noninferior alternative to the standard high-volume GoLYTELY in a cohort of hospitalized patients undergoing colonoscopy, a randomized trial showed ...

More patients taking GLP-1 receptor agonists require repeat colonoscopy due to poor bowel prep. HealthDay News — The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for diabetes or ...